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Abstract
Background: In situation like diagnosis of clinical and forensic samples there exists a need for highly sensitive,
rapid and specific DNA detection methods. Though conventional DNA amplification using PCR can provide fast
results, it is not widely practised in diagnostic laboratories partially because it requires skilled personnel and
expensive equipment. To overcome these limitations nanoparticles have been explored as signalling probes for
ultrasensitive DNA detection that can be used in field applications. Among the nanomaterials, gold nanoparticles
(AuNPs) have been extensively used mainly because of its optical property and ability to get functionalized with a
variety of biomolecules.
Results: We report a protocol for the use of gold nanoparticles functionalized with single stranded oligonucleotide
(AuNP- oligo probe) as visual detection probes for rapid and specific detection of Escherichia coli. The AuNP- oligo
probe on hybridization with target DNA containing complementary sequences remains red whereas test samples
without complementary DNA sequences to the probe turns purple due to acid induced aggregation of AuNP-
oligo probes. The color change of the solution is observed visually by naked eye demonstrating direct and rapid
detection of the pathogenic Escherichia coli from its genomic DNA without the need for PCR amplification. The
limit of detection was ~54 ng for unamplified genomic DNA. The method requires less than 30 minutes to
complete after genomic DNA extraction. However, by using unamplified enzymatic digested genomic DNA, the
detection limit of 11.4 ng was attained. Results of UV-Vis spectroscopic measurement and AFM imaging further
support the hypothesis of aggregation based visual discrimination. To elucidate its utility in medical diagnostic, the
assay was validated on clinical strains of pathogenic Escherichia coli obtained from local hospitals and spiked urine
samples. It was found to be 100% sensitive and proves to be highly specific without any cross reaction with non-
Escherichia coli strains.
Conclusion: This work gives entry into a new class of DNA/gold nanoparticles hybrid materials which might have
optical property that can be controlled for application in diagnostics. We note that it should be possible to extend
this strategy easily for developing new types of DNA biosensor for point of care detection. The salient feature of
this approach includes low-cost, robust reagents and simple colorimetric detection of pathogen.
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Background
The development of highly sensitive and selective DNA
detection methods is extremely important in clinical
diagnosis, forensic investigations and gene therapy
because the DNA is usually present at very low concen-
trations [1-3]. Although conventional DNA amplification
using PCR can provide fast results, it is not widely used
in the diagnostic laboratories of developing countries
partially because it requires considerable skill and
expensive equipment. To overcome these problems
nanoparticles have been explored as signalling probes
for ultrasensitive DNA detection that can be used in
field applications. Among the nanomaterials, gold nano-
particles (AuNPs) have been extensively used for biomo-
lecule detection by many research groups mainly
because of its optical property and ability to functiona-
lize with a variety of biomolecules. The AuNPs have
been integrated in research and routine diagnostic
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applications and have been shown to have the great
potential [4,5]. The colloidal AuNPs are used in the
development of several biodetection schemes [6-10].
Although protein-coated gold colloids have been used
extensively in lateral flow immunoassay based analytical
techniques their application towards DNA detection has
been introduced by Mirkin and co-workers [11]. The
functionalization of colloidal AuNPs with alkyl thiol
modified DNA is the most common ones. Such
approach was used for preparing stable oligonucleotide
conjugates with Au [12], Au-coated Ag [13] and ZnS-
coated CdSe nanoparticles [14]. Considerable work was
carried out that explore the basic properties of gold
nanoparticles [15-17]. DNA-functionalized AuNPs are
used in a variety of molecular diagnostic applications
such as high sensitivity DNA detection in homogenous
solution [18] and microarray- based DNA detection
[19], lab-on-chip based substrates [20-22], atomic force
microscopy based detection [23], detection of polymer-
ase chain reaction (PCR) amplicons [24,25]. The optical
property of colloidal AuNPs forms the basis of its appli-
cation in rapid and specific hybridization based DNA
detections. This property has already been applied for
detection of eukaryotic gene expression [26], Mycobac-
terium tuberculosis detection [27,28] and for RNA quan-
tification to detect chronic myeloid leukaemia [29].
Using a parallel approach we extend the application of
AuNPs conjugated oligonucleotide probes (AuNP- oligo
probes) as a tool for rapid detection of bacterial patho-
gen from clinical isolates. In this context, we demon-
strated the utility of the assay on diarrhogenic and
uropathogenic Escherichia coli strains obtained from
patients of local hospitals.
Diagnosis of Escherichia coli infections requires bac-
terial culture that needs one to two days of incubation,
and subsequent confirmatory testing. Rapid detection
methods like enzyme immunoassay require a high popu-
lation of the target pathogen [30,31]. In contrast, mole-
cular diagnostic assays like PCR based approaches
require fewer amounts of sample but dedicated equip-
ments and trained technical personnel. Hence there
exists always a need for rapid clinical diagnosis of patho-
gens at low cost. Our approach to using hybridization of
oligonucleotides for the controlled assembly of gold
nanoparticles under acidic environment for detection of
Escherichia coli is outlined in Figure 1. In brief, the
hybridization of the AuNP- oligo probe with the com-
plementary Escherichia coli genomic DNA remains red.
However the solution turns purple without complemen-
tary DNA. The method relies on a visual comparison of
solutions for color change before and after acid induced
aggregation of AuNP- oligo probe. Notably, the conco-
mitant color change of the solution can be observed by
naked eye. The assay was further evaluated by UV-Vis
spectroscopic characterization, which demonstrates
aggregation induced red-shift in AuNP- oligo probes.
Additionally dispersion and aggregation pattern of
AuNP- oligo probes respective to the hybridization was
monitored at nanoscale using AFM. The application of
the developed assay to medical diagnostics was shown a)
clinical isolates and b) urine-spiked clinical samples.
This study demonstrates the application of AuNP- oligo
probes for visual detection of pathogen at genomic
DNA level which can be adapted as a routine screening
tool in clinical laboratories.
Methods
Bacterial strains and reagents
The uropathogenic Escherichia coli (UPEC) were
obtained from Sundaram Medical Foundation (SMF)
hospital and Government General Hospital (GH), Chen-
nai. Shiga-toxin producing diarrhogenic Escherichia coli
O157 was obtained from Christian Medical College
(CMC), Vellore. Reference strains of Escherichia coli and
non-Escherichia coli organisms were obtained from
Microbial Type Culture Collection (MTCC), Institute of
Microbial Technology, Chandigarh. All the organisms
were cultured in Luria-Bertoni (LB) broth at 37°C for 16-
18 hours at 195 rpm. All clinical isolates were character-
ized biochemically followed by PCR using primer pairs
targeting fimH gene of Escherichia coli [32] prior to vali-
dation by AuNP- oligo probe assay. The details of PCR
cycling conditions were described in additional file 1.
The colloidal gold nanoparticles of size 20 nm were pur-
chased from Sigma and stored at 4°C until use. The silica
spin column for DNA extraction was purchased from
Qiagen. All other chemicals were of analytical grade and
used as purchased without further modifications.
Probe design
Probe sequence was designed based on the malB gene
region that has the high homology among the Escheri-
chia coli strains. A 20 base oligonucleotide was gener-
ated as probe sequence using the NCBI BLAST
nucleotide search tool [33]. Care is taken in designing
the sequence so that it does not share any sequence
homology with non- Escherichia coli family members.
Additionally, the melting temperature of the probes was
ensured to be within a narrow range. Further the
sequence is checked for potential self-complementarities
and also formation of secondary structures was verified
using mfold software [34] which may otherwise hinder
the assay. The final 20 base probe sequence obtained
was 5’ TACAAAGGGAGAAGGGCATG 3’. It contains
a thiol modifier at 5’ end to enable conjugation with the
colloidal gold nanoparticles. This 5’ alkyl thiol modified
oligonucleotide with HPLC purification was purchased
from Sigma.
et al. Journal of Nanobiotechnology 2012, 10:8
http://www.jnanobiotechnology.com/content/10/1/8
Page 2 of 10
Preparation of AuNP-oligo probe
The AuNP- oligo probe was synthesized using a pre-
viously described protocol [35]. Briefly, the 4 nmol thiol
modified oligonucleotide was initially incubated with 1
ml of AuNPs overnight in an orbital shaker at room tem-
perature wrapped in aluminium foil. At the end of reac-
tion, phosphate buffer (100 mM, pH7) was added to
obtain a final concentration of 9 mM. The surfactant
solution containing sodium dodecyl sulphate was added
resulting in a concentration of 0.1% and incubated in an
orbital shaker for 30 minutes. The salting solution (2 M
NaCl in 10 mM PBS pH7) was divided in six doses and
added to the above solution over the course of the two
days to reach a final concentration of 0.3 M NaCl. After
the last salt addition the solution is allowed to equilibrate
overnight at room temperature. Then centrifuged at
13000 xg for 20 minutes and the precipitate was washed
with 500 μl of resuspension buffer containing 10 mM
PBS (pH7.4), 150 mM NaCl, 0.1% SDS and resuspended
in 50 μl of the same buffer. The fully functionalized
AuNP- oligo probes retain the same color as the un-
modified AuNPs with no visible aggregates, and stored in
light-tight containers at room temperature until use.
Genomic DNA isolation
The genomic DNA was isolated from the organisms
using silica spin column as described elsewhere with
slight modifications [36]. The organisms were inoculated
in 10 ml of LB broth and grown overnight at 37°C in a
shaker at 195 rpm. A two ml of culture was taken in a
micro centrifuge tube and the pellet was collected after
centrifugation at 6,000 xg for two minutes. The pellet
was resuspended in 500 μl of lysis buffer (4.7 M guani-
dium thiocyanide, 46 mM Tris-HCl pH 6.4, 20 mM
EDTA and 1.2 w/v% Triton X-100) and incubated at 37°
C for 15 minutes. After incubation the cell lysate was
transferred to column and centrifuged at 6,000 xg for
three minutes. Collection tube was removed and the col-
umn washed with 650 μl of wash buffer (5.25 M guani-
dium thiocyanide and 50 mM Tris-HCl pH 6.4) at 6,000
xg for three minutes. Subsequently the column washed
thrice with 70% ethanol followed by a dry spin at 6,000
xg for three minutes to remove any trace amount of etha-
nol in the column. Fifty microlitres of nuclease free water
was added to the center of the column and incubated at
room temperature for one minute and centrifuged at
10,000 xg for three minutes to elute the DNA. The con-
centration of genomic DNA was quantified at 260 nm
using UV-VIS spectrophotometer (Cary 4000). The geno-
mic DNA was stored at -20°C until use.
AuNP- oligo probe hybridization assay
The complementary oligonucleotide
(5’CATGCCCTTCTCCCTTTGTA3’) specific to the
Figure 1 Schematic representation of working of AuNP- oligo probe assay. a) In the presence of Escherichia coli genomic DNA, AuNP-
oligo probes are stabilized and prevented from aggregation upon acid addition. Red color of the solution indicates presence of target DNA and
hence POSITIVE. b) In the presence of non Escherichia coli genomic DNA, AuNP- oligo probes loses its stability and tend to aggregate. Purple
color of the solution indicates absence of target DNA and hence NEGATIVE.
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probe sequence was obtained from Sigma. The comple-
mentary oligonucleotide from 100 μM stock was diluted
(29.8 ng, 11.94 ng, 5.97 ng, 2.98 ng) in 10 mM PBS buf-
fer (pH 5) to the final volume of ten microlitres. The
DNA was heated to 95°C for five minutes and three
microlitres of AuNP- oligo probe was added immedi-
ately followed by incubation at 65°C for ten minutes.
Blank samples were prepared in exactly the same way
using an equivalent volume of 10 mM PBS (pH5)
instead of DNA. The negative control was prepared
using non complementary DNA (5’GCCCTGACGAA-
GAAGGTGGC3’) containing 61.9 ng of oligonucleotide
in the final volume of ten microlitres. After hybridiza-
tion the test sample was equally divided into two ali-
quots and subjected to gel electrophoresis and acid
challenge simultaneously. The color of the solution was
noted five minutes after the addition of 40 μl of 0.01 N
HCl and photographed. The 1.5% agarose gel was used
to demonstrate the hybridization of the probe with the
complementary DNA. After electrophoresis the gel was
stained for silver enhancement to visualize the migration
of gold nanoparticles. In addition the oligonucleotide
was chemically cleaved from the surface of the gold
nanoparticles [35]. The retrieved oligonucleotide was
hybridization with complementary DNA to conform the
attachment of oligonucleotides to the surface of gold
nanoparticles (See additional file 1).
AuNP- oligo probe assay on genomic DNA
The hybridization protocol for complementary oligonu-
cleotide was directly applied on Escherichia coli genomic
DNA obtained from MTCC and found to be satisfactory
for reliable detection. To determine the minimum quan-
tity of DNA that can be detected using AuNP- oligo
probe assay, ten microlitres of DNA in the concentra-
tion range of 215 ng, 108 ng, 54 ng and 27 ng was serial
diluted from 430 ng of stock DNA in 10 mM PBS
(pH5). Each dilution was tested in AuNP- oligo probe
assay. Blank samples containing PBS instead of genomic
DNA was used as control for visual comparison and
characterized by UV-Vis spectrophotometer (Ocean
Optics USB4000) to demonstrate the surface plasmon
resonance shift in the samples. To determine the effect
of pre-treatment of DNA on detection limit of the assay,
genomic DNA was subjected to enzymatic digestion
using EcoRV enzyme (New England Biolabs) as recom-
mended by the supplier. Briefly, 57 ng of genomic DNA
was mixed with 1 μl of 10× NEB buffer and 0.1 μl of 10
mg/ml BSA in the total volume of 10 μl. The above
mixture was incubated at 37°C for 1 hour followed by
80°C for 20 minutes to stop the reaction. Also, same
amount of genomic DNA was sonicated for five minutes
in an ultrasonic bath (Branson 1510, 70 W, 42 KHz). In
both the methods the DNA fragmentation were verified
by agarose gel electrophoresis. The fragmented DNA
samples were serially diluted (22.8 ng, 11.4 ng, 5.7 ng)
and hybridized with AuNP- oligo probe. After hybridiza-
tion, the reaction mixture was equally divided and sub-
jected to acid challenge and gel electrophoresis.
Evaluation on clinical isolates
We obtained 31 Escherichia coli clinical samples from
patients with suspected enteric infections with known
culture and biochemical based examination results, and
we tested these isolates with AuNP-oligo probes based
method. We analyzed 30 negative strains consisting of
six samples in each of Klebsiella pneumoniae, Pseudo-
monas aeruginosa, Proteus mirabilis, Salmonella Typhi
and Salmonella ParatyphiA. The source of organisms
used for the assay was listed in Table 1. From each spe-
cies, 100 ng genomic DNA is extracted through silica
spin column method, denatured at 95°C for ten minutes
and three microlitres of AuNP- oligo probes was added.
To this sample, 0.01 N HCl added and results are
recorded. To assess the repeatability of the method, test-
ing with the proposed assay was repeated five times for
each sample.
Preparation of spiked urine samples
The urine from normal person was spiked with uro-
pathogenic Escherichia coli isolated from urinary tract
infected patient. To prepare urine spiked clinical sam-
ples, 106 - 105 cfu/ml Escherichia coli were added to
one ml of urine and centrifuged at 14000 xg for 25 min-
utes. The supernatant was discarded and the pellet was
used for genomic DNA extraction as described above.
The genomic DNA was quantified and the average yield
was determined to be 50-60 ng. About 30 different clini-
cal (spiked) samples were independently assayed using
AuNP- oligo probe assay and by PCR. The details of the
PCR conditions were described in the additional file 1.
Subsequently to demonstrate the specificity of the assay,
the other major uropathogens namely, Klebsiella pneu-
monia, Pseudomonas aeruginosa and Proteus mirabilis
were also spiked in urine as described above and the
extracted genomic DNA was used for the AuNP- oligo
probe assay.
Imaging by Atomic Force Microscopy
AFM imaging was performed to examine the nature of
positive and negative samples under test condition.
Sample slides for AFM were made using freshly cleaved
mica sheets soaked in poly-l-lysine and incubated at
room temperature for 20 minutes. The excess poly-l-
lysine was washed with distilled water. Slides are baked
at 55°C for one hour. The sample for AFM imaging was
prepared on these slides as described previously with
slight modifications [37]. Briefly, the test samples after
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completion of assay were centrifuged at 13000 xg for 30
minutes and the pellet was washed twice in distilled
water to remove salt and unhybridized DNA. The pellet
was resuspended in 50 μl of distilled water and spread
over the poly-l-lysine coated mica sheets and incubated
at room temperature for 20 minutes. The excess sam-
ples were removed and mica sheets were washed twice
with distilled water and allowed to air dry at room tem-
perature. The images were obtained using Scanning
probe microscope (NanoscopeIII, Digital Instruments,
Santa Barbara, CA, USA) in contact mode on the air
using silicon nitrite tips.
Results and Discussion
Characterization of AuNP- oligo probe assay
Initially, the AuNP- oligo probe assay was optimized for
visual detection using 20 base complementary
sequences. It is noted that annealing at 65°C was deter-
mined to be the optimum temperature for hybridization
of AuNP- oligo probes and the target DNA. The com-
plementary DNA after hybridization with the AuNP-
oligo probe was separated by gel electrophoresis and
subjected to silver enhancement (Figure 2a). The gra-
dual decrease in migration of the gold nanoparticles was
observed with increase in concentration of the comple-
mentary DNA in the sample (Lane 2-6) when compared
to the migration of AuNP- oligo probe (Lane 1) and the
negative control (Lane 7). Thus hybridization was
revealed by shift in gold nanoparticle band towards
lower electrophoretic mobility. This in fact acts as an
evidence for conjugation of the oligonucleotide to the
surface of the gold nanoparticles. In turn the hybridiza-
tion was evident from the mobility-shift proportionate
to the concentration of the complementary DNA. In
Figure 2b no visual discrimination of color change from
red to purple was observed up to 2.8 ng of complemen-
tary DNA. Whereas the unhybridized AuNP-oligo probe
loses its stability and tends to aggregate upon acid addi-
tion. Expectedly, non complementary DNA exhibited
aggregation upon acid addition with visual change in
color of the solution from red to purple. This initial
validation in fact confirmed the AuNP- oligo probe
Table 1 Bacterial strains used for the evaluation of AuNP- oligo probe assay.
Organisms Collection centre* Number of isolates PCR Detection by AuNP-oligo probe assay
Uropathogenic MTCC, IMTECH 1 + +
Escherichia coli SMF Hospital 20 + +
(UPEC) GH Hospital 10 + +
Escherichia coli O157 CMC, Vellore 1 + +
Klebsiella pneumonia MTCC, IMTECH 1 _ _
SMF Hospital 5 _ _
Pseudomonas aeruginosa MTCC, IMTECH 1 _ _
SMF Hospital 5 _ _
Proteus mirabilis MTCC, IMTECH 1 _ _
SMF Hospital 5 _ _
Salmonella Typhi MTCC, IMTECH 1 _ _
SMF Hospital 5 _ _
Salmonella Paratyphi A MTCC, IMTECH 1 _ _
SMF Hospital 5 _ _
*SMF- Sundaram Medical Foundation Hospital, Chennai. GH- Government General Hospital, Chennai. CMC- Christian Medical College, Vellore. MTCC- Microbial
Type Culture Collection. IMTECH- Institute of Microbial Technology, Chandigarh.
Figure 2 a) Silver enhanced agarose gel showing AuNP- oligo
probe hybridization. Lane 1: AuNP- oligo probe alone. Samples
with increasing concentration of complementary DNA (Lane 2: 2.8
ng, Lane 3: 5.6 ng, Lane 4: 11 ng, Lane 5: 28 ng, Lane 6: 59 ng).
Lane 7: 61.9 ng of non complementary DNA. b) Corresponding
results recorded visually after acid challenge.
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hybridization with the target DNA present in test
sample.
AuNP- oligo probe assay for Escherichia coli
The AuNP- oligo probe assay is applied to the genomic
DNA isolated from Escherichia coli. Figure 3a shows
results of visual discrimination of positive and negative
samples along with control sample having PBS instead
of DNA. It is observed that the solution containing
Escherichia coli genomic DNA remains red, whereas the
solution containing
Pseudomonas aeruginosa genomic DNA and the con-
trol turned purple after addition of 0.01 N HCl (Figure
3a).
As outlined in Figure 1, hybridization of AuNP- oligo
probe with the target DNA formed double stranded
DNA helix that stabilizes the gold nanoparticles under
acidic environment and hence remains red. However, in
the absence of complementary DNA the AuNP- oligo
probes aggregate under acidic environment and the
solution turns purple. UV-Vis spectroscopic data for
these samples given in Figure 3b support the hypothesis
of aggregation induced visual discrimination of the sam-
ple. It is seen that sample containing Escherichia coli
genomic DNA showed characteristic absorbance peak of
AuNP at 520 nm (black line) due to collective excitation
of the free conduction band electrons of the dispersed
particles known as the surface plasmon resonance.
Whereas in the negative (red line) and control (green
line) samples exhibiting wide absorbance spectrum is
indicative of peak shift towards longer wavelength (≥600
nm) due to the coupling in the surface plasmons of the
particles in the aggregates. This behaviour is in confor-
mity to the theoretical descriptions of Mie scattering
from similar small aggregate clusters where the plasmon
resonance absorption of the aggregates give rise to addi-
tional long wavelength component in the optical absorp-
tion spectrum relative to the absorption spectra of
dispersed nanoparticles in the solutions [38]. The
observed pale blue to purple color solution is also in
agreement with this understanding.
Limit of detection
Various dilutions of Escherichia coli genomic DNA was
used to determine the limit of detection of the AuNP-
oligo probe assay. Figure 3c summarizes the results of
detection sensitivity obtained visually after acid addition.
It was observed that no visible change in color of the
solution occurred up to sample containing ~54 ng of
Escherichia coli genomic DNA below which the solution
turned purple indicating the aggregation of the AuNP-
oligo probes. All the samples were subsequently mea-
sured for their absorbance to evaluate the surface plas-
mon resonance peak shift respective to the presence of
different concentration of target DNA in the test sam-
ple. Figure 3d shows the dependence of the absorption
spectra of the AuNP- oligo probe on the target DNA
concentration ranging from 430 to 27 ng of genomic
DNA compared with the control sample. All the positive
samples were found to have the characteristic absor-
bance peak at 520 nm with gradual decrease in absor-
bance relative to the concentration of genomic DNA
present in the test sample. Whereas in the negative and
control samples exhibited the red shift in their spectra
with the absorbance peak shifted to longer wavelength
(≥600 nm) whereas there was considerable peak
decrease in 520 nm. Thus AuNP- oligo probe was found
to detect the presence of ~ 54 ng of genomic DNA of
target pathogen after acid induced aggregation defining
the minimum detection limit of the assay.
To further increase the detection limit of the assay,
the genomic DNA was pre-treated prior to use in the
assay and compared with that of untreated genomic
DNA. Figure 4 summarizes the results of detection limit
by gel electrophoresis and visual detection.
As observed in Figure 4a, the unhybridized AuNP-
oligo probe moved a longer distance (Lane1) compared
to the probe hybridized with the restriction digested
DNA (Lane 2-3) and sonicated DNA (Lane 4-5). To
note, the progressive retardation in the shift of the gold
nanoparticle band was observed with increasing concen-
tration of genomic DNA in the test sample (Lane 6-9).
Figure 3 a) Representative results recorded visually after acid
addition. Blank, positive, and negative denotes sample tubes
containing PBS, genomic DNA of Escherichia coli and Pseudomonas
aeruginosa respectively. Red color shows the presence of target and
purple indicates the absence. b) UV-Vis spectra of the respective
samples. c) Visual observation of minimum detection limit of AuNP-
oligo probes hybridized with serial dilutions of Escherichia coli
genomic DNA in 50 μl volume. d) UV-Vis spectra of the respective
samples showing characteristic absorption at 520 nm upto 54 ng
DNA and broad spectral shift for samples containing less than 54
ng DNA and control sample.
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This result is in agreement with the result of concentra-
tion dependent hybridization of AuNP- oligo probe with
the complementary DNA (Figure 2). In this way, we
believe that gel electrophoresis is a very powerful
method to investigate the hybridization of target
sequence to the AuNP- oligo probe. Thus specific and
non specific attachment of DNA can be detected with
high sensitivity. The representative results observed
visually after acid addition was summarized in Figure
4b. However the AuNP- oligo probe failed to show
increase in the detection sensitivity of the assay on soni-
cated genomic DNA, attributed to the fact that sonica-
tion may lead to random shearing of DNA with many
single stranded nicks. These data in total suggest that
restriction digestion of genomic DNA can efficiently
improve the detection limit of the assay from ~54 ng to
11.4 ng.
Evaluation of specificity on clinical isolates
In order to obtain an indication of the methods perfor-
mance on clinical samples, we applied the optimized
assay on DNA isolated from the bacterial species listed
in Table 1. In total 31 Escherichia coli clinical samples
were tested in the assay and were found to be true posi-
tives. During the evaluation we found that all true nega-
tives in the AuNP- oligo probe assay was negative
controls confirmed in our laboratory by PCR. Figure 5
gives representative snap-shot of visual observations of
various negative controls compared with Escherichia coli
strain exhibiting visible color change of the solution
from red to purple after acid addition. Thus the
discrimination of Escherichia coli and non- Escherichia
coli strains were accomplished visually without the need
of any sophisticated instrument. The application of the
proposed method on the DNA isolated from the clinical
isolates produced exactly the same results every time (n
= 5) when the assay was repeated. Hence the assay
defines to have 100% specificity and repeatability thus
enabling reliable and highly specific detection without
any cross reaction with related bacteria. An interesting
feature of this assay is that the positive samples when
preserved overnight at room temperature continues to
retain its color suggesting the long-time stability of
AuNP- oligo probe hybridization with the target
sequence. This feature is particularly useful for pro-
longed read-out capability required for high-throughput
applications.
Validation on clinical samples
The genomic DNA extracted from spiked urine samples
were used for AuNP- oligo probe assay. The assay
detected all 30 urine spiked uropathogenic Escherichia
coli strains with zero cross reactivity against closely
related uropathogens namely, Pseudomonas aeruginosa,
Klebsiella pneumoniae and Proteus mirabilis. Indepen-
dently, PCR was performed on these entire samples with
same quantity of genomic DNA used for AuNP- oligo
probe assay (See additional file 1). The primer pair spe-
cific for detection of uropathogenic Escherichia coli
were used as described elsewhere [32]. All samples gave
specific amplicons without any discrepancy with the
results of AuNP- oligo probe assay. Usually the diagno-
sis of urinary tract infection was based on a quantitative
urine culture yielding greater than 105 cfu/ml of urine,
which was termed significant bacteriuria. This value was
Figure 4 a) Hybridization of AuNP- oligo probe with genomic
DNA. Lane 1: AuNP- oligo probe. Lane 2-3: Hybridization with 22.8
ng and 11.4 ng of restriction digested DNA respectively. Lane 4-5:
Hybridization with 22.8 ng and 11.4 ng of sonicated DNA
respectively. Lane 6-9: Hybridization with 430 ng, 215 ng, 108 ng, 54
ng of untreated genomic DNA respectively. b) Corresponding
results recorded visually after acid challenge.
Figure 5 Representative snap shot of AuNP- oligo probe assay
on DNA samples of indicated bacterial species. Escherichia coli
sample exhibit red color confirming the presence of target DNA. All
other samples exhibit purple color suggesting the absence target
DNA.
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arrived because of its high specificity to the diagnosis of
true infection, even in asymptomatic persons [39]. The
range of detection of our AuNP- oligo probe assay is
well within this limit. We further show that pre-treat-
ment of genomic DNA with restriction digestion can
fivefold increase the detection limit on the real clinical
samples. Therefore this assay proves to be an efficient
alternative to conventional culture based detection.
Thus a rapid method for identifying uropathogenic
Escherichia coli directly from clinical sample has been
developed. We note that 100% positive results were
obtained every time (n = 3) when using AuNP- oligo
probes prepared in three batches spread over a period
of six months. This proves the repeatability of the assay
and the robustness of AuNP- oligo probe.
AFM Characterization
High resolution images of nanoparticles by AFM have
been successfully used in the past to study of DNA-
nanoparticle interactions [23,37,38,41]. To elucidate the
nature of AuNP- oligo probe and target DNA interac-
tion in our test samples, AFM images of these com-
plexes are taken. Figure 6a shows the representative
image of AuNP- oligo probe hybridized with Escherichia
coli genomic DNA (positive samples). Interestingly,
there is no evidence of gold nanoparticles growth as the
hybridized probes seem to be remarkably regular in size
with an average diameter of 20 nm. Note that fine
monodispersed gold nanoparticles were observed despite
large concentration of sample immobilized on the sub-
strate surface. The results suggest that the nanoparticles
remain separated from one another without aggregation.
In sharp contrast, large scale aggregation of gold nano-
particles is observed in the presence of Pseudomonas
genomic DNA, a non-complementary target, in the test
sample (Figure 6b). We imply that single stranded probe
oligonucleotide on the surface of gold nanoparticles
could not prevent them from aggregation under acidic
condition. Therefore, it can be concluded that the for-
mation of nanoparticle aggregates is indeed due to the
absence of complementary DNA in the solution. This
result further explains data on characteristic absorption
spectra of positive and negative samples shown in Figure
3b. The optical property of gold nanoparticle studied by
UV-Vis spectroscopy gave quantitative information
about the degree of aggregation, indicating whether the
particles are well separated from one another or
whether they predominantly form aggregates. This opti-
cal property qualitatively correlates with the structural
features studied by AFM.
In summary, we have elucidated the utility of AuNP-
oligo probe as a signalling probe for rapid detection of
Escherichia coli. Though there exist many methods
using AuNPs for detection such as scanometric [42],
surface enhanced Raman scattering [43] and electroche-
mical techniques [44], AuNPs based colorimetric detec-
tion continue to hold great potential in point of care
based applications. Most useful attributes of this system
is the fact that AuNP- oligo probes can maintain good
dispersion in solution and posses shelf-life more than
six months at room temperature. Using UV-Vis spectro-
scopy and AFM imaging, we have quantitatively demon-
strated accuracy and reliability of visual detection
method. Striking feature of this protocol is the require-
ment of very low concentration of genomic DNA for
detection. We emphasize that even though molecular
detection methods like PCR and a more recent technol-
ogy of real-time PCR constitute robust and sensitive
Figure 6 AFM image of AuNP- oligo probe assay. a) Monodispersed gold nanoparticles in the presence of Escherichia coli genomic DNA in
the test sample. b) Three dimensional aggregates of gold nanoparticles in the presence of Pseudomonas aeruginosa genomic DNA in the test
sample.
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technique, it requires sensitive equipment and trained
personnel. The salient feature of the methodology devel-
oped here combines the gold standard of DNA based
detection with a simplified and user-friendly protocol
for point-of-care application. An important goal for
improved diagnosis is the development of rapid and
accurate method for detection of bacterial pathogens.
Most current clinical methods that identify bacterial
strains require time-consuming culture of the sample or
procedures involving polymerase chain reaction. Neither
of these approaches has enabled testing at the point -of-
need because of requirement of skilled technicians and
laboratory facilities. We believe this approach could
hold potential as next generation diagnostic tools. This
is a significant advance in DNA based diagnostics.
Conclusion
In this paper, an ultrasensitive and rapid DNA detection
technique based on AuNPs functionalized with single
stranded oligonucleotide probe was demonstrated. This
AuNP- oligo probe strategy allowed for visual detection
of Escherichia coli from its genomic DNA of the order
of 11.4 ng when the genomic DNA was pre-treated by
restriction digestion. AFM and UV-Vis spectroscopic
investigations give evidence to the formation of gold
nanoparticle aggregates in the solution. To demonstrate
the relevance of the methodology for clinical diagnostics,
extensive validation was performed on clinical (spiked)
samples. The results demonstrate the assay to be highly
sensitive and reliable screening tool for rapid detection
of Escherichia coli causing urinary tract infection. The
detection of presence of bacteria could be performed
with high sensitivity and specificity within the turn-
around time of 30 minutes. We emphasize that the
clinically relevant detection limit of ≥105 cfu/ml for hav-
ing high specificity on asymptomatic persons is easily
met in our assay. We believe that use of nanoparticles
based detection has pushed the measurement sensitivity
level comparable to those demonstrated by traditional
molecular biology methodologies. Finally, the proposed
method represents a generic gold nanoparticle based
platform technology that has the potential point of care
application for clinical detection of bacterial pathogens.
They open a further possibility of designing new devices
with their unique local optical properties.
Additional material
Additional file 1: Characterization and validation of AuNP- oligo
probe assay. Hybridization of complementary DNA with chemically
cleaved oligonucleotide retrieved from AuNP- oligo probe. Detection of
urine spiked clinical samples by PCR.
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(AuNPs): gold nanoparticles; (AuNP- oligo probe): AuNP conjugated
oligonucleotide probe.
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